SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001765581-19-000086
Filing Date
2019-08-14
Accepted
2019-08-14 17:33:58
Documents
1
Period of Report
2019-08-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 4730
  Complete submission text file 0001765581-19-000086.txt   6258
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN L2 4 L2
Business Address
Treacy Paul (Reporting) CIK: 0001615763 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 191027776